Humira 40 mg solution for injection in pre-filled syringe, Abatacept
IM101-863
Phase 3 small_molecule active
Quick answer
Humira 40 mg solution for injection in pre-filled syringe, Abatacept for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active